| scholarly article | Q13442814 |
| P50 | author | Matthew E. Falagas | Q87082633 |
| Petros I Rafailidis | Q87082992 | ||
| P2860 | cites work | Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies | Q33237577 |
| The significance of Acinetobacter baumannii bacteraemia compared with Klebsiella pneumoniae bacteraemia: risk factors and outcomes | Q34560229 | ||
| The epidemiology and control of Acinetobacter baumannii in health care facilities | Q36382140 | ||
| Antimicrobial resistance and patient outcomes: the hazards of adjustment | Q36596794 | ||
| Does antibiotic selection impact patient outcome? | Q36672883 | ||
| Multidrug-resistant Acinetobacter infection mortality rate and length of hospitalization | Q37302581 | ||
| Risk factors of mortality for nosocomial pneumonia: importance of initial anti-microbial therapy. | Q43656567 | ||
| The influence of inadequate empirical antimicrobial treatment on patients with bloodstream infections in an intensive care unit | Q44786185 | ||
| Carbapenem-resistant Acinetobacter baumannii in intensive care unit patients: risk factors for acquisition, infection and their consequences | Q45048702 | ||
| Impact of imipenem resistance on mortality in patients with Acinetobacter bacteraemia | Q57212401 | ||
| Colonization or Infection with Multidrug-Resistant Acinetobacter baumannii May Be an Independent Risk Factor for Increased Mortality | Q57232598 | ||
| Attributable mortality of Acinetobacter baumannii infection among critically ill patients | Q79804918 | ||
| Attributable mortality of nosocomial Acinetobacter bacteremia | Q79839567 | ||
| Comparison of mortality of patients with Acinetobacter baumannii bacteraemia receiving appropriate and inappropriate empirical therapy | Q83181290 | ||
| P433 | issue | 3 | |
| P921 | main subject | Acinetobacter baumannii | Q3241189 |
| P304 | page(s) | 134 | |
| P577 | publication date | 2007-01-01 | |
| P1433 | published in | Critical Care | Q5186602 |
| P1476 | title | Attributable mortality of Acinetobacter baumannii: no longer a controversial issue | |
| P478 | volume | 11 |
| Q27008568 | Acinetobacter baumannii: evolution of a global pathogen |
| Q38008459 | Acinetobacter baumannii: human infections, factors contributing to pathogenesis and animal models |
| Q26861494 | Acinetobacter infection--an emerging threat to human health |
| Q35628300 | Acinetobacter infections and outcomes at an academic medical center: a disease of long-term care |
| Q28257612 | An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii |
| Q27024893 | Antimicrobial resistance in Acinetobacter baumannii: From bench to bedside |
| Q36928268 | Biofilm Formation and Motility Depend on the Nature of the Acinetobacter baumannii Clinical Isolates |
| Q52649122 | Carbapenem-Nonsusceptible Acinetobacter baumannii, 8 US Metropolitan Areas, 2012-2015. |
| Q37183330 | Carbapenem-resistant Acinetobacter ventilator-associated pneumonia: Clinical characteristics and outcome |
| Q40866140 | CipA of Acinetobacter baumannii Is a Novel Plasminogen Binding and Complement Inhibitory Protein |
| Q36178130 | Clinical outcomes of tigecycline in the treatment of multidrug-resistant Acinetobacter baumannii infection |
| Q60044653 | Clinical, immunological and bacteriological characteristics of H7N9 patients nosocomially co-infected by Acinetobacter Baumannii: a case control study |
| Q36504353 | Clinico-microbiological profile and outcomes of nosocomial sepsis in an Indian tertiary care hospital--a prospective cohort study |
| Q36228369 | Colistin Dosage without Loading Dose Is Efficacious when Treating Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia Caused by Strains with High Susceptibility to Colistin. |
| Q45974680 | Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trial. |
| Q38212031 | Combination antibiotic treatment versus monotherapy for multidrug-resistant, extensively drug-resistant, and pandrug-resistant Acinetobacter infections: a systematic review |
| Q41364861 | Comparative genome sequence analysis of multidrug-resistant Acinetobacter baumannii |
| Q21135285 | Deciphering the multifactorial nature of Acinetobacter baumannii pathogenicity |
| Q33676198 | Detection of KPC in Acinetobacter spp. in Puerto Rico |
| Q97521500 | Development of Different Methods for Preparing Acinetobacter baumannii Outer Membrane Vesicles Vaccine: Impact of Preparation Method on Protective Efficacy |
| Q55378575 | Differential characteristics of Acinetobacter baumannii colonization and infection: risk factors, clinical picture, and mortality. |
| Q41075973 | Discovery and Characterization of New Hydroxamate Siderophores, Baumannoferrin A and B, produced by Acinetobacter baumannii |
| Q54207272 | Distribution of virulence-associated genes and antimicrobial susceptibility in clinical Acinetobacter baumannii isolates. |
| Q37270368 | Epidemiology and burden of multidrug-resistant bacterial infection in a developing country |
| Q100385051 | Epidemiology and clinical outcomes associated with extensively drug-resistant (XDR) Acinetobacter in US Veterans' Affairs (VA) medical centers |
| Q59796484 | Extensively drug-resistant and association in a Romanian intensive care unit: risk factors for acquisition |
| Q35127885 | Hospital acquired antibiotic-resistant acinetobacter baumannii infections in a 400-bed hospital in Tehran, Iran. |
| Q36298237 | Impact of empirical antimicrobial therapy on the outcome of critically ill patients with Acinetobacter bacteremia. |
| Q37392820 | In vitro activity and in vivo efficacy of clavulanic acid against Acinetobacter baumannii. |
| Q47687534 | In vitro effects of tigecycline in combination with colistin (polymyxin E) and sulbactam against multidrug-resistant Acinetobacter baumannii |
| Q40019977 | In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan. |
| Q28552411 | Molecular Epidemiology and Clinical Impact of Acinetobacter calcoaceticus-baumannii Complex in a Belgian Burn Wound Center |
| Q33626986 | Multidrug resistant Acinetobacter baumannii: a descriptive study in a city hospital |
| Q37656243 | Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy |
| Q46459710 | Next-gen sequencing of multi-drug resistant Acinetobacter baumannii to determine antibiotic resistance genotypes |
| Q40883429 | Nosocomial Acinetobacter pneumonia: Treatment and prognostic factors in 356 cases |
| Q37663353 | Nosocomial infections in pediatric population and antibiotic resistance of the causative organisms in north of iran |
| Q64059196 | Procalcitonin-guided antibiotic discontinuation in ventilator-associated pneumonia: a prospective observational study |
| Q37735085 | Prognosis of patients with Acinetobacter baumannii infection in the intensive care unit: A retrospective analysis |
| Q39991867 | Regulation of Acinetobacter baumannii biofilm formation |
| Q36664034 | Risk Factors and Clinical Outcomes for Patients With Acinetobacter baumannii Bacteremia |
| Q84332021 | Risk factors for 30-day mortality in patients with carbapenem-resistant Acinetobacter baumannii during an outbreak in an intensive care unit |
| Q35805487 | Role of acinetobactin-mediated iron acquisition functions in the interaction of Acinetobacter baumannii strain ATCC 19606T with human lung epithelial cells, Galleria mellonella caterpillars, and mice |
| Q64110714 | Seasonal Occurrence and Carbapenem Susceptibility of Bovine in Germany |
| Q36423689 | Sequential outbreaks of infections by distinct Acinetobacter baumannii strains in a public teaching hospital in Houston, Texas |
| Q54960487 | Severe Community-Acquired Pneumonia due to Acinetobacter baumannii in North America: Case Report and Review of the Literature. |
| Q92494772 | The Role of Minocycline in the Treatment of Nosocomial Infections Caused by Multidrug, Extensively Drug and Pandrug Resistant Acinetobacter baumannii: A Systematic Review of Clinical Evidence |
| Q38125493 | The role of antimicrobial stewardship in curbing carbapenem resistance |
| Q35731104 | Translation Elongation Factor Tuf of Acinetobacter baumannii Is a Plasminogen-Binding Protein |
| Q36448641 | Treatment of ventilator-associated pneumonia and ventilator-associated tracheobronchitis in the intensive care unit. A national survey of clinicians and pharmacists in Saudi Arabia. |
| Q91741099 | Volatilomes of Bacterial Infections in Humans |
Search more.